Triple antibiotic therapy with ceftolozane/tazobactam, colistin and rifampin for pan-resistant Pseudomonas aeruginosa ventilator-associated pneumonia
Emergence of multi-drug resistant microorganisms such as pan-resistant Pseudomonas aeruginosa has recently created a therapeutic challenge in ICU patients worldwide. New antipseudomonal antibiotics, like ceftolozane/tazobactam have been developed to meet this challenge. This drug does not demonstrat...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Southwest Respiratory and Critical Care Chronicles
2015-06-01
|
| Series: | Southwest Respiratory and Critical Care Chronicles |
| Subjects: | |
| Online Access: | http://pulmonarychronicles.com/index.php/pulmonarychronicles/article/view/206 |